Literature DB >> 22071052

Perinatal outcome in pregnancies complicated by isolated oligohydramnios diagnosed before 37 weeks of gestation.

Nir Melamed1, Joseph Pardo, Renana Milstein, Rony Chen, Moshe Hod, Yariv Yogev.   

Abstract

OBJECTIVE: To analyze pregnancy outcome in cases of isolated oligohydramnios at preterm.
METHODS: A retrospective cohort study of singleton pregnancies diagnosed with isolated oligohydramnios at preterm (n = 108). Pregnancy outcome was compared with a matched control group of low-risk preterm pregnancies with normal levels of amniotic fluid in a 3:1 ratio (n = 324).
RESULTS: Pregnancies complicated by isolated oligohydramnios were characterized by a higher rate of preterm deliveries (26.9% vs 12.3%, P < .001), most of which were iatrogenic, and a higher rate of labor induction and cesarean delivery. Neonates with isolated oligohydramnios were characterized by a lower birthweight and a higher rate of neonatal morbidity. These differences were eliminated when the analysis was limited to the subgroup of pregnancies with isolated oligohydramnios that were managed expectantly and delivered spontaneously at term.
CONCLUSION: Adverse pregnancy outcome in cases of isolated oligohydramnios diagnosed at <37 weeks appears to be related to a considerable degree to iatrogenic prematurity.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22071052     DOI: 10.1016/j.ajog.2011.06.013

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  7 in total

1.  Induction of Labor in Women with Oligohydramnios: Misoprostol Compared with Prostaglandin E2.

Authors:  Tetsuya Kawakita; Katherine L Grantz; Helain J Landy; Chun-Chih Huang; Michelle A Kominiarek
Journal:  Am J Perinatol       Date:  2016-07-11       Impact factor: 1.862

2.  Universal late pregnancy ultrasound screening to predict adverse outcomes in nulliparous women: a systematic review and cost-effectiveness analysis.

Authors:  Gordon Cs Smith; Alexandros A Moraitis; David Wastlund; Jim G Thornton; Aris Papageorghiou; Julia Sanders; Alexander Ep Heazell; Stephen C Robson; Ulla Sovio; Peter Brocklehurst; Edward Cf Wilson
Journal:  Health Technol Assess       Date:  2021-02       Impact factor: 4.014

3.  Use of trastuzumab in treating breast cancer during pregnancy: a systematic review and meta-analysis.

Authors:  Lin-Yu Xia; Qing-Lin Hu; Qing Zhou
Journal:  BMC Womens Health       Date:  2021-04-21       Impact factor: 2.809

Review 4.  Amniotic fluid as a vital sign for fetal wellbeing.

Authors:  Elizabeth A Dubil; Everett F Magann
Journal:  Australas J Ultrasound Med       Date:  2015-12-31

5.  Oligohydramnios: a prospective study of fetal, neonatal and maternal outcomes in low-middle income countries.

Authors:  Lester Figueroa; Elizabeth M McClure; Jonathan Swanson; Robert Nathan; Ana L Garces; Janet L Moore; Nancy F Krebs; K Michael Hambidge; Melissa Bauserman; Adrien Lokangaka; Antoinette Tshefu; Waseem Mirza; Sarah Saleem; Farnaz Naqvi; Waldemar A Carlo; Elwyn Chomba; Edward A Liechty; Fabian Esamai; David Swanson; Carl L Bose; Robert L Goldenberg
Journal:  Reprod Health       Date:  2020-01-30       Impact factor: 3.223

6.  The Inconsistency Between Women's Preference and Actual Mode of Delivery in China: Findings From a Prospective Cohort Study.

Authors:  Jing Wu; Li Feng; Hongwei Zhang; Li Guo; Rafael Pérez-Escamilla; Yifei Hu
Journal:  Front Public Health       Date:  2022-03-30

7.  Fetal left ventricular modified myocardial performance index and renal artery pulsatility index in pregnancies with isolated oligohydramnios before 37 weeks of gestation

Authors:  Rıza Madazlı; Hakan Erenel; Ayşegül Özel; Funda Öztunç
Journal:  J Turk Ger Gynecol Assoc       Date:  2020-06-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.